{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:22:26Z","timestamp":1780374146077,"version":"3.54.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ejogrb.2021.01.031","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T18:26:33Z","timestamp":1611858393000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Home fetal heart rate monitoring in anti Ro\/SSA positive pregnancies: Literature review and case report"],"prefix":"10.1016","volume":"259","author":[{"given":"Roberta","family":"Milazzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Ligato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2648-195X","authenticated-orcid":false,"given":"Arianna","family":"Laoreti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Basili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1396-8857","authenticated-orcid":false,"given":"Lisa","family":"Serati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-5600","authenticated-orcid":false,"given":"Antonio","family":"Brucato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2021.01.031_bib0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0090-1229(85)90045-5","article-title":"Antinuclear, anticytoplasmic, and anti-Sjogren\u2019s syndrome antigen A (SS-A\/Ro) antibodies in female blood donors","volume":"36","author":"Fritzler","year":"1985","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/096120339200100304","article-title":"Prevalence of non-organ-specific autoantibodies in pregnant and non-pregnant healthy women","volume":"1","author":"Mavridis","year":"1992","journal-title":"Lupus"},{"issue":"August(8)","key":"10.1016\/j.ejogrb.2021.01.031_bib0015","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C","article-title":"Risk of congenital complete heart block in newborns of mothers with anti-Ro\/SSA antibodies detected by counter immunoelectrophoresis: a prospective study of 100 women","volume":"44","author":"Brucato","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"August(8)","key":"10.1016\/j.ejogrb.2021.01.031_bib0020","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.3899\/jrheum.080737","article-title":"Congenital heart block not associated with anti-Ro\/La antibodies: comparison with anti-Ro\/La-positive cases","volume":"36","author":"Brucato","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0025","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0735-1097(98)00161-2","article-title":"Autoimmune associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry","volume":"31","author":"Buyon","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ejogrb.2021.01.031_bib0030","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrrheum.2015.29","article-title":"The clinical spectrum of autoimmune heart block","volume":"11","author":"Brito-Zer\u00f3n","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0035","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/1529-0131(199911)42:11<2335::AID-ANR12>3.0.CO;2-3","article-title":"Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody associated congenital heart block: retrospective review of the research registry for neonatal lupus","volume":"42","author":"Saleeb","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0040","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/CIRCULATIONAHA.107.707661","article-title":"Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study","volume":"117","author":"Friedman","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0045","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ajog.2016.07.002","article-title":"Detection and successful treatment of emergent anti- SSA-mediated fetal atrioventricular block","volume":"215","author":"Cuneo","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0050","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/S2665-9913(19)30069-4","article-title":"Repeated echocardiographic monitoring of fetuses exposed to maternal anti-SSA antibodies: time to question the dogma","volume":"1","author":"Costedoat-Chalumeau","year":"2019","journal-title":"Lancet Rheumatol"},{"issue":"April","key":"10.1016\/j.ejogrb.2021.01.031_bib0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bpobgyn.2019.09.001","article-title":"Autoimmune-mediated congenital heart block","volume":"64","author":"Wainwright","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"February 6","key":"10.1016\/j.ejogrb.2021.01.031_bib0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fcvm.2019.00011","article-title":"First report of the italian registry on immune-mediated congenital heart block (Lu.NE registry)","volume":"28","author":"Fredi","year":"2019","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.ejogrb.2021.01.031_bib0065","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1191\/0961203303lu408oa","article-title":"Proposal for a new definition of congenital complete atrioventricular block","volume":"12","author":"Brucato","year":"2003","journal-title":"Lupus"},{"issue":"November(11)","key":"10.1016\/j.ejogrb.2021.01.031_bib0070","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/art.40228","article-title":"Association of natural killer cell ligand polymorphism HLA-C Asn80Lys with the development of Anti-SSA\/Ro-Associated congenital heart block","volume":"69","author":"Ainsworth","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"September(5)","key":"10.1016\/j.ejogrb.2021.01.031_bib0075","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/BOR.0000000000000414","article-title":"Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupus","volume":"29","author":"Izmirly","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0080","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fcvm.2019.00054","article-title":"Autoimmune calcium channelopathies and cardiac electrical abnormalities","volume":"6","author":"Qu","year":"2019","journal-title":"Front Cardiovasc Med"},{"issue":"March(2)","key":"10.1016\/j.ejogrb.2021.01.031_bib0085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jaut.2009.06.005","article-title":"Congenital heart block: identification of autoantibody binding site on the extracellular loop (domain I, S5-S6) of alpha(1D) L-type Ca channel","volume":"34","author":"Karnabi","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0090","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/rheumatology\/ker515","article-title":"Anatomical and pathological findings in hearts from fetuses and infants with cardiac manifestations of neonatal lupus","volume":"51","author":"Llanos","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0095","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/art.11430","article-title":"Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage\/fibroblast crosstalk in the pathologic cascade leading to congenital heart block","volume":"50","author":"Clancy","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4049\/jimmunol.1800357","article-title":"Siglec-1 macrophages and the contribution of IFN to the development of autoimmune congenital heart block","volume":"202","author":"Clancy","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0105","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00431-016-2748-0","article-title":"Congenital and childhood atrioventricular blocks: pathophysiology and contemporary management","volume":"175","author":"Baruteau","year":"2016","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0110","series-title":"Complications of pregnancy","article-title":"Hydrops fetalis","author":"Sekar","year":"2019"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0115","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jpedsurg.2014.10.027","article-title":"The many faces of hydrops","volume":"50","author":"Derderian","year":"2015","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0120","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1161\/01.cir.0000437597.44550.5d","article-title":"Diagnosis and treatment of fetal cardiac disease: a scientific statement from the american heart association","volume":"129","author":"Donofrio","year":"2014","journal-title":"Circulation"},{"issue":"March(3)","key":"10.1016\/j.ejogrb.2021.01.031_bib0125","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women\u2019s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0130","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0002-9149(00)00867-5","article-title":"Pulsed Doppler echocardiographic assessment of the fetal PR interval","volume":"86","author":"Glickstein","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0135","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000074256","article-title":"The fetal Doppler mechanical PR interval: a validation study","volume":"19","author":"Glickstein","year":"2004","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0140","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/uog.7333","article-title":"Fetal Doppler mechanical PR interval: correlation with fetal heart rate, gestational age and fetal sex","volume":"34","author":"Wojakowski","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0145","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0002-9149(01)02130-0","article-title":"Reference values for time intervals between atrial and ventricular contractions of the fetal heart measured by two Doppler techniques","volume":"88","author":"Andelfinger","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0150","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/art.20126","article-title":"Signs of first\u2010degree heart block occur in one\u2010third of fetuses of pregnant women with anti\u2010SSA\/Ro 52\u2010kd antibodies","volume":"50","author":"Sonesson","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.ejogrb.2021.01.031_bib0155","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/pd.4454","article-title":"Outcomes of fetal echocardiographic surveillance in anti-SSA exposed fetuses at a large fetal cardiology center","volume":"34","author":"Krishnan","year":"2014","journal-title":"Prenat Diagn"},{"issue":"November(11)","key":"10.1016\/j.ejogrb.2021.01.031_bib0160","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.autrev.2017.09.005","article-title":"Should we treat congenital heart block with fluorinated corticosteroids?","volume":"16","author":"Brucato","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"Jul-Aug(4)","key":"10.1016\/j.ejogrb.2021.01.031_bib0165","first-page":"783","article-title":"Fluorinated steroids are not superior to any treatment to ameliorate the outcome of autoimmune mediated congenital heart block: a systematic review of the literature and meta-analysis","volume":"38","author":"Hoxha","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0170","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/jp.2016.220","article-title":"Heart sounds at home: feasibility of an ambulatory fetal heart rhythm surveillance program for anti- SSA-positive pregnancies","volume":"37","author":"Cuneo","year":"2017","journal-title":"J Perinatol"},{"issue":"October (16)","key":"10.1016\/j.ejogrb.2021.01.031_bib0175","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.jacc.2018.07.076","article-title":"Home monitoring for fetal heart rhythm during anti-ro pregnancies","volume":"72","author":"Cuneo","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0180","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-000989","article-title":"Type I IFN system activation in newborns exposed to Ro\/SSA and La\/SSB autoantibodies in utero","volume":"6","author":"Hedlund","year":"2020","journal-title":"RMD Open"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0185","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.4049\/jimmunol.1000702","article-title":"Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines","volume":"186","author":"Kuznik","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0190","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1124\/mol.113.089821","article-title":"Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in vivo","volume":"85","author":"Lamphier","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0195","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti\u2010SSA\/ro\u2010antibody\u2014associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0200","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2009.119263","article-title":"Evaluation of the risk of anti-SSA\/Ro-SSB\/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine","volume":"69","author":"Izmirly","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"July (3)","key":"10.1016\/j.ejogrb.2021.01.031_bib0205","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jacc.2020.05.045","article-title":"Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of Anti-SSA\/Ro-Positive mothers","volume":"76","author":"Izmirly","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0210","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"Skorpen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0215","first-page":"172","article-title":"Disease\u2010modifying anti\u2010rheumatic drug use in pregnant women with rheumatic diseases: a systematic review of the risk of congenital malformations","volume":"34","author":"Baldwin","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"May-Aug(2)","key":"10.1016\/j.ejogrb.2021.01.031_bib0220","first-page":"148","article-title":"Fetal cardiac arrhythmias: current evidence","volume":"11","author":"Bravo-Valenzuela","year":"2018","journal-title":"Ann Pediatr Cardiol"},{"issue":"March(3 Pt 1)","key":"10.1016\/j.ejogrb.2021.01.031_bib0225","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0002-9378(12)90827-3","article-title":"Umbilical pressure measurement in the evaluation of nonimmune hydrops fetalis","volume":"168","author":"Weiner","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"January (1)","key":"10.1016\/j.ejogrb.2021.01.031_bib0230","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2007.06.060","article-title":"Electrophysiological characteristics of fetal atrioventricular block","volume":"51","author":"Zhao","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0235","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.jacc.2010.12.014","article-title":"Prolongation of the atrioventricular conduction in fetuses exposed to maternal Anti\u2010Ro\/SSA and Anti\u2010La\/SSB antibodies did not predict progressive heart block: a prospective observational study on the effects of maternal antibodies on 165 fetuses","volume":"57","author":"Jaeggi","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"suppl. S5","key":"10.1016\/j.ejogrb.2021.01.031_bib0240","doi-asserted-by":"crossref","first-page":"v9","DOI":"10.1093\/rheumatology\/key141","article-title":"The prevention, screening and treatment ofcongenital heart block from neonatal lupus:a survey of provider practices","volume":"57","author":"Clowse","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0245","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1161\/CIRCULATIONAHA.108.773143","article-title":"Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti\u2010SSA\/Ro\u2010SSB\/La antibodies a prospective, observational, fetal kinetocardiogram\u2010based study","volume":"119","author":"Rein","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0250","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/BOR.0b013e32832ed817","article-title":"Prevention of complete heart block in children of mothers with anti\u2010SSA\/Ro and anti\u2010SSB\/La autoantibodies: detection and treatment of first\u2010degree atrioventricular block","volume":"21","author":"Mevorach","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0255","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/aogs.13338","article-title":"Maternal steroid therapy for fetuses with second\u2010degree immune\u2010mediated congenital atrioventricular block: a systematic review and meta\u2010analysis","volume":"97","author":"Ciardulli","year":"2018","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"September (12)","key":"10.1016\/j.ejogrb.2021.01.031_bib0260","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/01.CIR.0000142046.58632.3A","article-title":"Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease","volume":"110","author":"Jaeggi","year":"2004","journal-title":"Circulation"},{"issue":"Nov-Dec(6)","key":"10.1016\/j.ejogrb.2021.01.031_bib0265","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/CRD.0000000000000026","article-title":"Prevention and treatment in utero of autoimmune-associated congenital heart block","volume":"22","author":"Saxena","year":"2014","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0270","first-page":"706","article-title":"Plasmapheresis, intravenous immunoglobulins and bethametasone\u2010a combined protocol to treat autoimmune congenital heart block: a prospective cohort study","volume":"34","author":"Ruffatti","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejogrb.2021.01.031_bib0275","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/trf.13046","article-title":"Plasma exchange effectively removes 52\u2010 and 60\u2010kDa anti\u2010RO\/SSA and anti\u2010La\/SSB antibodies in pregnant women with congenital heart block","volume":"55","author":"Tonello","year":"2015","journal-title":"Transfusion"},{"issue":"April(4)","key":"10.1016\/j.ejogrb.2021.01.031_bib0280","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/art.27350","article-title":"Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study","volume":"62","author":"Pisoni","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"April(4)","key":"10.1016\/j.ejogrb.2021.01.031_bib0285","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/art.27308","article-title":"Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial","volume":"62","author":"Friedman","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.ejogrb.2021.01.031_bib0290","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1191\/0961203302lu252oa","article-title":"Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro\/SSA antibodies: a prospective controlled study","volume":"11","author":"Brucato","year":"2002","journal-title":"Lupus"},{"issue":"February(1)","key":"10.1016\/j.ejogrb.2021.01.031_bib0295","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12016-009-8190-6","article-title":"Pregnancy outcomes in patients with autoimmune diseases and anti-Ro\/SSA antibodies","volume":"40","author":"Brucato","year":"2011","journal-title":"Clin Rev Allergy Immunol"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521000452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521000452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:50:14Z","timestamp":1759557014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211521000452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":59,"alternative-id":["S0301211521000452"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.01.031","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Home fetal heart rate monitoring in anti Ro\/SSA positive pregnancies: Literature review and case report","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.01.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}